Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01434706 · ClinicalTrials.gov registry record · NA
Implementation of Nucleic Acid Amplification Testing Screening to Identify Acute and Early HIV Infection
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 22,607
- Enrollment target
NCT01434706: Completed NA study, sponsored by University of California, San Diego.
NCT01434706 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 22,607 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1511% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01434706, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 22,607 participants
- Enrollment target
Study Summary
The investigators propose to study the impact of nucleic acid amplification testing (NAT) screening for acute Human Immunodeficiency Virus (HIV) and Hepatitis C (HCV) infections and Less-Sensitive Enzyme linked Immunoassay (LS-EIA) or 'detuned' testing Vironostika, Trinity Biotech BED, or Ortho-Clinical Diagnostic Vistros ECi for early HIV infection in conjunction with routine rapid HIV testing at HIV counseling and testing sites and venues in the San Diego county. The overarching goal of this study is to develop and implement a system to identify, notify and engage into care those individuals with recent HIV infection in order to better define the HIV and Hepatitis C Virus (HCV) epidemics in the San Diego county and to evaluate and characterize HIV transmission dynamics within the San Diego population.
Primary Outcome
Positive detection of presence of HIV
Interventions
- OTHER Nucleic Acid Amplification Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22,607 participants |
| Start Date | 2010-09-16 |
| Est. Completion | 2015-04-07 |
| Phase | NA |
What the finished NCT01434706 record still lists
NCT01434706 is an interventional study that assigns participants to a tested intervention. Its 22,607 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1511% higher).
The record links to 0 conditions, and to 1 intervention - of which Nucleic Acid Amplification Testing is the first listed.
NCT01434706 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01434706 about?
NCT01434706 is a clinical study titled "Implementation of Nucleic Acid Amplification Testing Screening to Identify Acute and Early HIV Infection". The investigators propose to study the impact of nucleic acid amplification testing (NAT) screening for acute Human Immunodeficiency Virus (HIV) and Hepatitis C (HCV) infections and Less-Sensitive Enzyme linked Immunoassay (LS-EIA) or 'detuned' testing Vironostika, Trinity Biotech BED, or Ortho-Clin...
What is the current status of trial NCT01434706?
This trial is currently completed. It is a NA study. The enrollment target is 22,607 participants. The study started on 2010-09-16. Estimated completion is 2015-04-07.
What interventions are being tested in trial NCT01434706?
The interventions under investigation include: Nucleic Acid Amplification Testing (OTHER).
Who is sponsoring clinical trial NCT01434706?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01434706's enrollment target sits among peer trials
22,607 10th of 2000 higher than 1,991 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06486688 · 22,320 participants · NA
Centralized Virtual SBIRT for Pediatric Primary Care
- NCT07413211 · 22,068 participants
Genetic Developmental and Epileptic Encephalopathy Natural History Study for Clinical Trial Readiness
- NCT05488080 · 22,032 participants · NA
PAINED: Project Addressing INequities in the Emergency Department
- NCT05832307 · 22,000 participants · NA
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI